Literature DB >> 25676522

Nontuberculous mycobacteria infections in immunosuppressed hosts.

Emily Henkle1, Kevin L Winthrop2.   

Abstract

Diseases and therapies that reduce cell-mediated immunity increase the risk of nontuberculous mycobacterial (NTM) disease. Extrapulmonary NTM disease, including disseminated, skin, and catheter-related disease, is more common in immunosuppressed than immunocompetent patients. Mycobacterium avium complex remains the most common cause of NTM infection, but rapid growers including Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum play an important role in skin and catheter-related infections. With the exception of antibiotic prophylaxis for AIDS patients, the prevention of NTM remains difficult. Management is complicated, involving restoration of immune function and removal of catheters in addition to treatment with species-specific antibiotics per current guidelines.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Extrapulmonary nontuberculous mycobacteria; Immunosuppressive therapy; Mycobacterium avium; Transplant

Mesh:

Substances:

Year:  2014        PMID: 25676522      PMCID: PMC4710582          DOI: 10.1016/j.ccm.2014.11.002

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  61 in total

1.  Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.

Authors:  D Rebecca Prevots; Pamela A Shaw; Daniel Strickland; Lisa A Jackson; Marsha A Raebel; Mary Ann Blosky; Ruben Montes de Oca; Yvonne R Shea; Amy E Seitz; Steven M Holland; Kenneth N Olivier
Journal:  Am J Respir Crit Care Med       Date:  2010-06-10       Impact factor: 21.405

2.  Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection.

Authors:  Sarah K Browne; Rifat Zaman; Elizabeth P Sampaio; Kamonwan Jutivorakool; Lindsey B Rosen; Li Ding; Minjal J Pancholi; Lauren M Yang; Debra Long Priel; Gulbu Uzel; Alexandra F Freeman; Carlton E Hayes; Roger Baxter; Stuart H Cohen; Steven M Holland
Journal:  Blood       Date:  2012-03-08       Impact factor: 22.113

Review 3.  Mycobacterium avium complex infection in the acquired immunodeficiency syndrome.

Authors:  C R Horsburgh
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

Review 4.  Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs).

Authors:  Wen-I Lee; Jing-Long Huang; Kuo-Wei Yeh; Tang-Her Jaing; Tzou-Yien Lin; Yhu-Chering Huang; Cheng-Hsun Chiu
Journal:  J Formos Med Assoc       Date:  2011-12-23       Impact factor: 3.282

5.  Risk factors for nontuberculous mycobacterial infections in solid organ transplant recipients: a case-control study.

Authors:  S A Longworth; C Vinnard; I Lee; K D Sims; T D Barton; E A Blumberg
Journal:  Transpl Infect Dis       Date:  2013-12-19       Impact factor: 2.228

6.  Increased risk of nontuberculous mycobacterial infection in asthmatic patients using long-term inhaled corticosteroid therapy.

Authors:  Masayuki Hojo; Motoyasu Iikura; Satoshi Hirano; Haruhito Sugiyama; Nobuyuki Kobayashi; Koichiro Kudo
Journal:  Respirology       Date:  2012-01       Impact factor: 6.424

7.  Recurrent Mycobacterium haemophilum in a renal transplant recipient.

Authors:  Kathryn Ducharlet; Caitlin Murphy; Sven-Jean Tan; Karen M Dwyer; David Goodman; Craig Aboltins; John R Daffy; Robyn G Langham
Journal:  Nephrology (Carlton)       Date:  2014-04       Impact factor: 2.506

8.  Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy.

Authors:  C R Horsburgh; J A Havlik; D A Ellis; E Kennedy; S A Fann; R E Dubois; S E Thompson
Journal:  Am Rev Respir Dis       Date:  1991-09

9.  Hairy cell leukemia: association with disseminated atypical mycobacterial infection.

Authors:  R A Weinstein; H M Golomb; G Grumet; E Gelmann; G P Schechter
Journal:  Cancer       Date:  1981-07-15       Impact factor: 6.860

10.  Nontuberculous mycobacterial disease mortality in the United States, 1999-2010: a population-based comparative study.

Authors:  Mehdi Mirsaeidi; Roberto F Machado; Joe G N Garcia; Dean E Schraufnagel
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

View more
  80 in total

1.  Investigation of intra-herd spread of Mycobacterium caprae in cattle by generation and use of a whole-genome sequence.

Authors:  S Broeckl; S Krebs; A Varadharajan; R K Straubinger; H Blum; M Buettner
Journal:  Vet Res Commun       Date:  2017-02-13       Impact factor: 2.459

2.  Bloodstream Infections With a Novel Nontuberculous Mycobacterium Involving 52 Outpatient Oncology Clinic Patients-Arkansas, 2018.

Authors:  Sarah M Labuda; Kelley Garner; Michael Cima; Heather Moulton-Meissner; Alison Laufer Halpin; Nadege Charles-Toney; Peter Yu; Erin Bolton; Reid Pierce; Matthew B Crist; Danica Gomes; Paige Gable; Gillian McAllister; Adrian Lawsin; Hollis Houston; Naveen Patil; J Gary Wheeler; Robert Bradsher; Keyur Vyas; Dirk Haselow
Journal:  Clin Infect Dis       Date:  2020-10-23       Impact factor: 9.079

Review 3.  Macrophage Signaling Pathways in Pulmonary Nontuberculous Mycobacteria Infections.

Authors:  Zohra Prasla; Roy L Sutliff; Ruxana T Sadikot
Journal:  Am J Respir Cell Mol Biol       Date:  2020-08       Impact factor: 6.914

4.  Mycobacterium avium Infection of Nasal Septum in a Diabetic Adult: A Case Report.

Authors:  Liyan Xu; Elza Matrova; Nicholas Edward Dietz
Journal:  Head Neck Pathol       Date:  2016-06-20

5.  Production, crystallization and structure determination of a mycobacterial glucosylglycerate hydrolase.

Authors:  Tatiana Barros Cereija; Susana Alarico; Nuno Empadinhas; Pedro José Barbosa Pereira
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2017-09-01       Impact factor: 1.056

Review 6.  Cutaneous Mycobacterial Infections.

Authors:  Carlos Franco-Paredes; Luis A Marcos; Andrés F Henao-Martínez; Alfonso J Rodríguez-Morales; Wilmer E Villamil-Gómez; Eduardo Gotuzzo; Alexandro Bonifaz
Journal:  Clin Microbiol Rev       Date:  2018-11-14       Impact factor: 26.132

7.  Phylogenetic and Biochemical Analyses of Mycobacterial l,d-Transpeptidases Reveal a Distinct Enzyme Class That Is Preferentially Acylated by Meropenem.

Authors:  Trevor A Zandi; Robert L Marshburn; Paige K Stateler; Leighanne A Brammer Basta
Journal:  ACS Infect Dis       Date:  2019-10-14       Impact factor: 5.084

Review 8.  Gender susceptibility to mycobacterial infections in patients with non-CF bronchiectasis.

Authors:  Mehdi Mirsaeidi; Ruxana T Sadikot
Journal:  Int J Mycobacteriol       Date:  2015-06

9.  Antimicrobial Susceptibility and Phylogenetic Relations in a German Cohort Infected with Mycobacterium abscessus.

Authors:  Nils Wetzstein; Thomas A Kohl; Tilman G Schultze; Sönke Andres; Carla Bellinghausen; Christian Hügel; Volkhard A J Kempf; Annette Lehn; Michael Hogardt; Hubert Serve; Maria J G T Vehreschild; Timo Wolf; Stefan Niemann; Florian P Maurer; Thomas A Wichelhaus
Journal:  J Clin Microbiol       Date:  2020-11-18       Impact factor: 5.948

10.  Understanding Mycobacterium avium subspecies hominissuis microaggregate mediated pathogenesis.

Authors:  Fernando Lopes Leivas Leite
Journal:  Virulence       Date:  2015       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.